Mar 18 |
Adverum Biotechnologies GAAP EPS of -$0.23 beats by $0.11
|
Mar 18 |
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates
|
Mar 6 |
Turn Pocket Change into Profit: 3 Penny Stocks Ready to Pop
|
Mar 4 |
Adverum Biotechnologies to sell 106.48M shares for holders
|
Feb 28 |
Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care Conference
|
Feb 27 |
Stocks on the Launchpad: The Next 3 Market Sensations
|
Feb 22 |
Unleash Massive Returns With These 3 Top Penny Stocks
|
Feb 12 |
Adverum Biotechnologies to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
Feb 11 |
Wall Street Breakfast: The Week Ahead
|
Feb 8 |
Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMD
|